HeartFlow shares are up +25.64% in regular trading Friday at $38.96, versus the prior close of $31.01. The move extends an after-hours surge following Q2 results: revenue rose +48% year-over-year to $64.1 million, beating forecasts, and adjusted loss per share of -$0.07 was much narrower than expected.

NU is trading up +13.07% at $15.75 in early regular trading, extending an after-hours/premarket surge after Q2 results were released following Thursday's close. Primary catalyst: Q2 2026 net income reached a record $1.06 billion, its first billion-dollar quarter, up +49% year over year and above consensus; revenue rose +39% to $5.88 billion.

ENHA is down -18.00% during regular trading on Aug. 14, sliding to about $2.05 from a prior close of $2.50. The selloff follows Q2 results released after the Aug. 13 close, with revenue of $17.71M missing expectations by $6.89M and GAAP EPS of -$0.53.

MRLN fell -16.74% in Friday's regular session to $3.68, down from Wednesday's close of $4.42. The drop follows Q2 2026 results reported after Wednesday's close: revenue of about $2.2 million missed the roughly $3.8 million consensus, and an adjusted loss of $1.11 per share was far wider than the $0.28 expected.

KinderCare Learning (KLC) is down -26.50% to $3.55 in early regular trading, extending losses that began after-hours Wednesday. The selloff follows Q2 adjusted EPS of $0.08, missing the $0.10 consensus, with revenue down -0.4% YoY to $697.5M.

YSS is down -11.03% to $10.24 in early regular trading on Aug. 14, versus a prior close of $11.51. The decline extends a post-earnings selloff that began after the Aug. 13 close and steepened in premarket trading, where shares fell roughly -15% at the lows.

ARS Pharmaceuticals (SPRY) is trading down -10.25% at $5.48 in early regular trading, versus a $6.10 close on Aug 13. The move follows Q2 results released after the prior close: EPS came in at -$0.63, missing the -$0.50 consensus, while revenue of $33.7M beat the $31.5M estimate.

Modular Medical (MODD) closed at $1.87 on August 13, 2026, down approximately 57% from the $4.31 closing price recorded 30 calendar days earlier on July 14, 2026. The decline has pushed the stock toward the lower end of its 52-week range of $1.74–$30.00 and well below its 50-day moving average near $3.64.

Nuwellis shares closed at $1.30 on August 13, 2026, down from $3.12 on July 15, 2026, a decline of approximately 58% over the last 30 days. The selloff was driven primarily by dilutive capital-raising activity, including a registered direct offering priced at $2.59 per share on July 31, 2026, and warrant exercise proceeds.

SNWV fell approximately 60% over the last 30 days, from a closing price of $11.96 on July 14, 2026, to $4.77 on August 13, 2026. Second-quarter 2026 revenue of $9.7 million declined 3% year over year and missed consensus estimates near $11.5 million, while the company swung to a net loss of $0.7 million.

NIVF shares fell roughly 59.9% over the 30 days through the August 13, 2026 close, declining from $1.37 to about $0.55. The move extends a deeper downtrend, with the stock down approximately 79.6% over the trailing three months.

Tapestry, Inc. (TPR) reported fiscal 2026 fourth-quarter net sales of $1.88 billion, up 9% year over year, for the period ended June 27, 2026. Adjusted earnings per share (EPS) rose 27% to $1.32, exceeding the consensus estimate of $1.28.

Credicorp Ltd. (NYSE: BAP) reported 2Q26 net profit attributable to shareholders of S/1.98 billion, up 8.8% year over year but down 3.9% from 1Q26. Return on equity (ROE), a measure of profitability, reached 20.3%, down from 21.1% in the prior quarter but above the company's full-year guidance of around 19.5%.

Revenue: JD.com reported second-quarter 2026 net revenues of RMB346.4 billion (US$51.1 billion), down 2.9% year over year but above the consensus estimate of about RMB342.7 billion. Earnings beat: Non-GAAP diluted earnings per American depositary share (ADS) reached RMB6.29 (US$0.93), topping the analyst estimate of RMB5.63.

Nu Holdings reported second-quarter 2026 net income of $1.1 billion, its first quarter above $1 billion, up 49% year over year on a foreign-exchange-neutral (FXN) basis. Gross revenue reached nearly $5.9 billion, up 39% year over year on an FXN basis, while reported revenue of $5.88 billion came in above the roughly $5.39 billion consensus estimate.

Distributable earnings before realizations rose 15% per share year over year to $1.427 billion, or $0.61 per share. Total distributable earnings reached $1.548 billion, or $0.66 per share, up from $1.385 billion, or $0.59 per share, a year earlier.

Applied Materials posted record revenue of $9.12 billion for its fiscal third quarter ended July 26, 2026, up 25% year over year and above the consensus estimate of about $8.99 billion. Non-GAAP EPS (earnings per share) reached a record $3.50, beating the roughly $3.40 consensus; GAAP EPS was $3.17.

iShares MSCI Emerging Markets ETF (EEM) provides broad passive exposure to large- and mid-cap equities across emerging markets via the MSCI Emerging Markets Index, holding approximately 1,197 securities with an expense ratio of 0.72%. Freedom 100 Emerging Markets ETF (FRDM) employs a freedom-weighted strategy that prioritizes countries with higher personal, political, and economic freedom scores, resulting in a more concentrated portfolio of about 130 holdings and a lower expense ratio of 0.49%.

Netflix (NFLX) shares have recovered to approximately $74 after hitting a two-year low near $66 during the July 17 post-earnings sell-off, reflecting a roughly 30-day net change of about 1%. The Q2 2026 earnings report slightly beat EPS estimates but missed on revenue, while weaker-than-expected Q3 guidance and a decision to reduce engagement disclosures triggered a sharp one-day drop of over 7%.

Braskem S.A. (BAK) has fallen about 22% over the past 30 days, from a $2.67 close on July 14, 2026, to the latest available price near $2.08 in mid-August. The decline reflects unresolved debt-restructuring negotiations, creditor rejection of the company's initial proposal, and a June court-protection filing that led S&P Global Ratings to cut Braskem to 'D'.